SEC Form D filing

HAWKHILL THERAPEUTICS Ltd

Biotech · Seed · Regulation D 506(b) · Filed June 23, 2026

Websitehawkhilltherapeutics.com

Offering amount: $192.6K
Exemption: Reg D 506(b)
Issuer state: Not disclosed
Filing date: June 23, 2026
Signature date: June 22, 2026
CIK: 0002140690

Summary

Auto-generated

The issuer is classified under biotechnology due to "Therapeutics" in its name. The company filed a Rule 506(b) offering of $192,569 on June 23, 2026.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.